Skip to main content
. 2007 Mar 7;2007:80687. doi: 10.1155/2007/80687

Table 2.

Hyperhomocysteinaemia and MTHFR polymorphism distributions according to CAD, and HHcy distribution according to MTHFR polymorphism and CAD. P1 is an MTHFR polymorphism and HHcy comparison (chi-square test) and Hcy comparison (ANOVA and median tests) between cases and controls. P2 is the significant value of the hypothesis testing that the OR of CAD associated to MTHFR polymorphism and HHcy is 1. P3 is a tHcy comparison between genotypes in cases and controls separately (Kruskal-Wallis test). P4 is a tHcy comparison between genotypes in total population (Kruskal-Wallis test).

Total population Control Case P1 OR (95% CI) P2

Number of subjects 400 190 210

MTHFR C677T
 Genotype, n (%) 0.038
 677CC 214 (53.5) 113 (59.5) 101 (48.1) 1.00
 677CT 139 (34.8) 61 (32.1) 78 (37.1) 1.43 (0.93–2.20) 0.102
 677TT 47 (11.8) 16 (8.4) 31 (14.8) 2.17 (1.12–4.20) 0.022
 Allele, n (%) 0.006
 677C 567 (70.9) 287 (75.5) 280 (66.7) 1.00
 677T 233 (29.1) 93 (24.5) 140 (33.3) 1.54 (1.11–1.84) 0.007

tHcy, μmol/L
 Mean ± SD 13.1 ± 3.6 11.3 ± 3.1 14.8 ± 3.1 0.000
 Median 13.8 11.1 14.9 0.000
HHcy, n (%) 0.000
 No 256 (64.0) 150 (78.9) 106 (50.5) 1.00
 Yes 144 (36.0) 40 (21.1) 104 (49.5) 3.68 (2.37–5.72) 0.000

MTHFR polymorphism

Total population 677CC 677CT 677TT P3 P4

Number of subjects 400 214 139 47

tHcy, μmol/L 0.000
 Case 14.9 ± 3.1 13.7 ± 2.3 15.0 ± 2.4 18.3 ± 4.0 0.000
 Control 11.3 ± 3.1 10.5 ± 3.0 11.9 ± 2.9 14.1 ± 2.2 0.000

HHcy, n (%) 0.007
 Case 104 (26.0) 35 (16.4) 42 (30.2) 27 (57.4) 0.000
 Control 40 (10.0) 18 (8.4) 14 (10.1) 8 (17.0) 0.007